Why is $DTIL moving today? · SEC 8-K archive

$DTIL SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $DTIL: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $DTIL filing catalyst

Why did $DTIL trigger an AI stock catalyst alert?

$DTIL triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.5/10). Headline: Precision BioSciences Reports Q3 Net Loss of $7.6M, Cash Balance at $108M. Key points: - Zero revenue reported for Q3 2026 compared to $13k in Q3 2025; Net loss narrowed to $7.59M ($0.28 per share) vs $21.77M ($1.84 per share). - Cash, cash equivalents, and restricted cash stood at $108.0M as of Sept 30, down from $137.2M at year-end 2025. - Pipeline updates include an upcoming late-breaking oral presentation on PBGENE-HBV on Nov 8 and first patient dosed in PBGENE-DMD Phase 1/2 study.

How did $DTIL stock react after the SEC filing?

After the SEC 8-K for $DTIL, observed market reaction: T0 price $6.95. Past moves do not guarantee future results.

Where can I get real-time $DTIL SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $DTIL via Telegram and the VIP Web Terminal from €10/month.

$DTIL

$DTIL – Precision BioSciences Reports Q3 Net Loss of $7.6M, Cash Balance at $108M

PRECISION BIOSCIENCES INC

2026-11-03 00:00:00 UTC · SEC 8-K · All $DTIL

Unlocked archive · Analyzed in <2s at T0

Bearish AI Sentiment (-1.5 / 10)

Zero revenue reported for Q3 2026 compared to $13k in Q3 2025; Net loss narrowed to $7.59M ($0.28 per share) vs $21.77M ($1.84 per share).
Cash, cash equivalents, and restricted cash stood at $108.0M as of Sept 30, down from $137.2M at year-end 2025.
Pipeline updates include an upcoming late-breaking oral presentation on PBGENE-HBV on Nov 8 and first patient dosed in PBGENE-DMD Phase 1/2 study.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →